Elite Pharmaceuticals, Inc. (ELTP)

Market Cap	561.91M
Revenue (ttm)	122.89M
Net Income (ttm)	13.92M
Shares Out	1.07B
EPS (ttm)	0.01
PE Ratio	40.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,223,738
Average Volume	931,760
Open	0.5134
Previous Close	0.5199
Day's Range	0.5050 - 0.5244
52-Week Range	0.2700 - 0.8194
Beta	0.28
RSI	36.03
Earnings Date	Nov 14, 2025

About Elite Pharmaceuticals

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments. It owns, licenses, manufactures, and sales of generic, oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P brand; P...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 68
• Stock Exchange: OTCMKTS
• Ticker Symbol: ELTP